D.Western Therapeutics Institute Modifies Financial Covenants on Loan Agreements

TOKYO, Aug 03 (Pulse News Wire) – D.Western Therapeutics Institute, Inc. (4576.T) announced changes to financial covenants on loan agreements originally established on April 16, 2020, and June 30, 2022.

The modifications aim to align with updated development timelines for treatments DW-5LBT and DWR2,206 due to delays since initial plans. Under the revised agreement, the company must maintain positive net asset balances in its standalone and consolidated balance sheets at fiscal year-end and hold fixed deposits exceeding outstanding borrowings from Mizuho Bank.

The modified contracts cover principal amounts of ¥100 million and ¥440 million, with repayment deadlines set for September 30, 2029, and June 30, 2030, respectively. The impact on the company's consolidated performance for the fiscal year ending December 2026 is expected to be minor.